New research is being presented at ADA 2014, the 74th Scientific Sessions of the American Diabetes Association, from June 13-17 in San Francisco.
Meeting Highlights
The Effects of Diet on Diabetes Risk
Diabetes Missed in Many Asian Americans
Can Hepatitis B Vaccination Prevent Diabetes?
Long-Term Effects of Diabetes Prevention
Is It Depression or Diabetes Distress?
News From ADA 2014
Weekly GLP-1 Agonist Matches Daily Victoza in T2D
Targets Tightened for Kids’ Type 1 Diabetes
Canola Oil Cuts Heart Risk in Diabetes
Victoza Lowers Glucose in Genetic Form of Diabetes
Baby Formula Doesn’t Prevent Type 1 Diabetes
New Rivals to Top Diabetes Drug Lantus Show Promise in Studies
Combination Diabetes Drug Effective After 1 yr-Study
Depression Predicts Type 1 Diabetes Death, but Hope Prevails
First-Ever ADA Guidance Specifically for Type 1 Diabetes
“Bionic Pancreas” Works for 5 Days in Outpatient Settings
Statins Not Cost-Effective for Many Newly Eligible Patients
Sulfonylureas May Up Fracture Risk in Diabetes, Along With TZDs
Girl Power: Islet Transplants from Women Donors Work Better
Is Celiac Screening for Kids With Type 1 Diabetes Adequate?
ACC/AHA Lipid Guidelines: A Step up in Diabetes Care, or Not?
Lipid, Blood Pressure Guidelines in the Spotlight
Insulin Analogs: Is Benefit Worth Cost in Type 2 Diabetes?
Cutting-Edge Science Tops ADA Agenda in San Francisco
More From ADA 2014
